Previous close | 0.2620 |
Open | 0.2200 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 0.2200 - 0.2350 |
52-week range | 0.2200 - 0.2350 |
Volume | |
Avg. volume | N/A |
Market cap | N/A |
Beta (5Y monthly) | -0.21 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Significant Improvement in Net Loss and Record Medical Revenue Highlight the Quarter
Achieved record-high Medical revenue of $36.0 million in Q1 2024, a 34.6% increase versus the prior year period and a 12.6% sequential increase versus Q4 2023.Net loss improved by $6.0 million versus the prior year to $(4.2) million in Q1 2024; Adjusted EBITDA improved by $4.2 million versus the prior year to $(3.5) million in Q1 2024.Record-high Medical Segment Adjusted EBITDA of $4.4 million in Q1 2024, up 134.5%, while Passenger Segment Adjusted EBITDA improved by $0.4 million, versus the pri
NEW YORK, April 23, 2024 (GLOBE NEWSWIRE) -- Blade Air Mobility, Inc. (Nasdaq: BLDE, “Blade” or the “Company”), today announced the opening of the shareholder Q&A platform to be used for its upcoming conference call to discuss the financial results for the fiscal fourth quarter ended March 31, 2024. Blade will conduct the call at 8:00am ET on Tuesday, May 7, 2024. Starting today, any shareholder will be able to submit and upvote questions to management of the Company. To submit questions ahead o